TCGX Acquisition Corp. II (NASDAQ:TCXB)
| Market Cap | 105.60M-6.3% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 10.00M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 27,243 |
| Open | 10.37 |
| Previous Close | 10.40 |
| Day's Range | 10.37 - 10.76 |
| 52-Week Range | 10.34 - 11.74 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About TCXB
TCGX Acquisition Corp. II is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands and formed to identify and complete a merger, share exchange, asset acquisition, or similar business combination with one or more businesses. The company has not selected a specific acquisition target and may pursue opportunities across any industry or geographic market. It is sponsored by TCGX Sponsor II, LLC, an affiliate of TCG Crossover Management, LLC, an investment firm focused on healthcare and life sciences.
$TCXB stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in TCXB holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by TCXB's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
TCXB Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New TCXB patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to TCXB from public contracts
Source: USAspending.gov
TCXB Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from TCXB’s recent data — informational, not investment advice